Literature DB >> 17657742

HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN.

Jenny Briolat1, Véronique Dalstein, Maëlle Saunier, Karine Joseph, Stéphanie Caudroy, Jean-Luc Prétet, Philippe Birembaut, Christine Clavel.   

Abstract

Human papillomavirus (HPV) infection is the most important event in malignant transformation of human cervical epithelium. We analysed in cervical smears, HPV genotypes with a focus on single/multiple infections, then characteristics of HPV-16 infections (presence of other genotypes, viral load and physical state) according to the grade of histological lesions. The purpose of this study was to know if these parameters could allow to differentiate histological diagnoses. DNA was extracted from 363 cervical samples corresponding to 24 cases without lesion, 96 CIN1, 92 CIN2, 144 CIN3 and 7 cancers. Our results show that HPV-16 was predominant and its prevalence increased with the severity of lesions (CIN1: 27.1%; CIN3: 65.3%). In addition, we showed that the frequency of single infections, as compared with multiple infections, increased with the severity of the lesion (CIN1: 25.0%; CIN3: 54.8%). Among HPV-16 positive samples (n = 170), we found that viral load, determined on cervical samples by real-time PCR, did not vary significantly according to the different CIN grades. Concerning HPV-16 integration, the mixed and integrated HPV-16 forms, already present in women with normal histology, increased to the benefit of pure episomal forms with the severity of lesions (normal cervix: 28.6%; CIN3: 73.8%). Thus, our data raise the question of the viral load as a valuable clinical parameter to discriminate between lesion grades. Moreover, we emphasize integration as an early event in cervical carcinogenesis, increasing with the severity of lesions. Finally, this study underlines the importance of single versus multiple infections linked to the severity of CIN. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657742     DOI: 10.1002/ijc.22959

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

3.  Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.

Authors:  Yuling Dong; Qiufen Tan; Lin Tao; Xiaolin Pan; Lijuan Pang; Weihua Liang; Wei Liu; Wenjie Zhang; Feng Li; Wei Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Physical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study.

Authors:  Anna Manawapat; Frank Stubenrauch; Rainer Russ; Christian Munk; Susanne Kruger Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

5.  Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology.

Authors:  Andreas Clad; Miriam Reuschenbach; Johanna Weinschenk; Ruth Grote; Janina Rahmsdorf; Nikolaus Freudenberg
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

6.  Association of HPV16 and 18 genomic copies with histological grades of cervical lesions.

Authors:  Negar Joharinia; Ali Farhadi; Seyed Younes Hosseini; Akbar Safaei; Jamal Sarvari
Journal:  Virusdisease       Date:  2019-07-22

7.  Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.

Authors:  Mina Kalantari; Kathryn Osann; Itzel E Calleja-Macias; Seong Kim; Bing Yan; Sara Jordan; Dana M Chase; Krishnansu S Tewari; Hans-Ulrich Bernard
Journal:  Virology       Date:  2013-11-09       Impact factor: 3.616

8.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

9.  Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation.

Authors:  Mina Kalantari; Luisa L Villa; Itzel E Calleja-Macias; Hans-Ulrich Bernard
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

10.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.